FDA Inspection 1077627 — Midwest Center For Reproductive Health
The FDA completed an inspection of Midwest Center For Reproductive Health on Dec 20, 2018 in Maple Grove, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 20, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Maple Grove, MN (United States)